Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colonic Polyps × Eflornithine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Adenomatous Polyposis Coli 2 Urinary Bladder Neoplasms 1 Precancerous Conditions 1 Glioma 1 Colonic Polyps 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

sodium phosphate 1 prucalopride 1 picosulfate sodium 1 Sulindac 1 Ringer's Lactate 1 Polyethylene Glycols 1 Hydroxyethyl Starch Derivatives 1 Eflornithine 1 Diatrizoate Meglumine 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01245816 2015-04-24

A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)

Cancer Prevention Pharmaceuticals, Inc.

Phase 3 Withdrawn

Gastrointestinal

Colonic Polyps, Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon ⚡